Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA058988-02S1
Application #
2099614
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1993-04-01
Project End
1997-01-31
Budget Start
1994-07-12
Budget End
1995-01-31
Support Year
2
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Ohio State University
Department
Type
Schools of Pharmacy
DUNS #
098987217
City
Columbus
State
OH
Country
United States
Zip Code
43210
Chu, Audrey Y; Workalemahu, Tsegaselassie; Paynter, Nina P et al. (2013) Novel locus including FGF21 is associated with dietary macronutrient intake. Hum Mol Genet 22:1895-902
Au, Jessie L-S; Jang, Seong H; Wientjes, M Guill (2002) Clinical aspects of drug delivery to tumors. J Control Release 78:81-95
Au, J L; Badalament, R A; Wientjes, M G et al. (2001) Methods to improve efficacy of intravesical mitomycin C: results of a randomized phase III trial. J Natl Cancer Inst 93:597-604
Gan, Y; Mo, Y; Kalns, J E et al. (2001) Expression of DT-diaphorase and cytochrome P450 reductase correlates with mitomycin C activity in human bladder tumors. Clin Cancer Res 7:1313-9
Li, D; Gan, Y; Wientjes, M G et al. (2001) Distribution of DT-diaphorase and reduced nicotinamide adenine dinucleotide phosphate: cytochrome p450 oxidoreductase in bladder tissues and tumors. J Urol 166:2500-5
Gao, X; Au, J L; Badalament, R A et al. (1998) Bladder tissue uptake of mitomycin C during intravesical therapy is linear with drug concentration in urine. Clin Cancer Res 4:139-43
Yen, W C; Schmittgen, T; Au, J L (1996) Different pH dependency of mitomycin C activity in monolayer and three-dimensional cultures. Pharm Res 13:1887-91